US 9326950
Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs
granted A61KA61K9/5169A61P
Quick answer
US patent 9326950 (Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K9/5169, A61P, A61P35/00, A61P35/04